Highlights from the Congress,
Wednesday, June 01
The Wednesday programme started off with a plenary session on the theme "Future therapeutic challanges" where different therapies and technologies were discussed.
The workshop programme rounded off the last congress day and in a well attended session, EAS President, Professor Alberico Catapano, University of Milan, Italy, overviewed what is new in the recently published Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Read the report from the Guidelines session >>
From the Plenary Programme
Although first envisaged in the realm of oncology, Wednesday’s plenary discusses the application of this approach for cardiometabolic disease. The development of metabolomics technologies, which combine genetic and functional information, is one driver, as discussed by Karsten Suhre, Weill Cornell Medicine, Qatar.
In an exciting overview, Matthias H. Tschöp, Helmholtz Diabetes Center & Technische Universität München, Munich, Germany, provided a rationale for metabolic precision medicine in the development of pharmacotherapy for obesity and related metabolic disorders.
In the plenary session, Erik Stroes, Academic Medical Center, Amsterdam, the Netherlands, highlighted novel approaches in targeted therapy for atherosclerosis, which aim to optimize the benefit/risk profile. "Novel therapies will help to tailor treatment to the high risk individual, with antibody/antisense approaches offering the possibility of precise molecular targeting. Finally, nanomedicine offers the possibility of improving efficacy and minimizing the risk of side effects."
To the full Wednesday sessions report >>
From the Workshop programme
EAS President, Professor Alberico Catapano, Italy, overviewed what was new in the recently published Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, in a special Congress session. He focused on key areas including risk assessment, goals and targets for important cardiovascular risk factors, recommendations for imaging, and lipid control, as well as intervention strategies.
Read the Guideline session report >>
Listen to Professor Catapano in an interview on the guidelines >>
Read the full Wednesday sessions report >>